Category: Business

Pegfilgrastim Biosimilars Insights Pegfilgrastim biosimilar is a biologic medicine that is highly similar to the reference therapy pegfilgrastim, used to reduce the risk of infection in cancer patients undergoing chemotherapy. Biosimilars undergo rigorous testing to demonstrate their similarity in terms of safety and efficacy. The market outlook for pegfilgrastim biosimilars is promising, with increasing demand for cost-effective and accessible cancer care. As more pegfilgrastim biosimilars enter the market, competition is expected to drive down prices and improve patient access to this critical supportive therapy.